Compare Davita Inc (DVA) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while GraniteShares 2x Long NVDA Daily ETF trades at $38.31 (market cap $3.56B). The key difference: Davita Inc is far larger — about 3.2× GraniteShares 2x Long NVDA Daily ETF's market cap, and GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.
| DVA | NVDL | |
|---|---|---|
Market Cap | $11.29B | $3.56B |
Volume | 582,204 | 9,740,643 |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $43.02 |
52-Week Low | $103.87 | $21.76 |
Typical Hold Time | 113 Days | 15 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $39.57, down 1.49% amid mixed technical signals. While moving averages show strong bullish momentum with 13 buy signals, oscillators remain neutral and short-term RSI readings suggest overbought conditions near 75. The ETF tracks Nvidia's performance with 2x daily leverage, benefiting from Nvidia's continued AI leadership and recent earnings beats, though it has underperformed the underlying stock over the past year with 17.21% gains versus NVDA's 22.21%.
The outlook remains cautiously optimistic given Nvidia's dominant AI position and technical breakout potential, but leveraged ETF structure introduces volatility decay risks. Key resistance sits at $41 with support at $39. Investors face concentration risk in the single-stock ETF approach while benefiting from Nvidia's $6 trillion market cap target narrative and strong institutional interest in AI infrastructure plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →
